While Hug et al. found no increased telomerase activity in CD4+ and CD8+ T cells from MS patients [271], Thewissen et al. measured significantly reduced TERT mRNA levels in stimulated blood cells of patients with MS as compared to healthy controls [272]. This evidence concerns the gene CD4 and myeloid sarcoma.